Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Toxicities and outcomes of neoadjuvant treatment in elderly patients with locally advanced rectal cancer: A scoping review.
Authors
Ruba Ahmed Mohammed Hamed
School of Medicine, Limerick, Ireland;
Ruba Ahmed Mohammed Hamed , Greg Korpanty , Dervla Kella
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Symptoms, Toxicities, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 91)
DOI
10.1200/JCO.2023.41.4_suppl.91
Abstract #
91
Poster Bd #
E8
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
NANORAY-312: A phase III pivotal study of NBTXR3 activated by investigator’s choice of radiotherapy alone or radiotherapy in combination with cetuximab for platinum-based chemotherapy-ineligible elderly patients with locally advanced head and neck squamous cell carcinoma.
First Author: Christophe Le Tourneau
Poster
2022 ASCO Gastrointestinal Cancers Symposium
SONCAR study: A prospective randomized controlled study on optimized neoadjuvant chemotherapy-oxaliplatin plus CRT in patients with locally advanced rectal cancer.
First Author: Rong-Xin Zhang
Poster
2020 ASCO Virtual Scientific Program
Is there a benefit of oxaliplatin in neoadjuvant treatment of locally advanced rectal cancer? An updated meta-analysis.
First Author: Gaetan Des Guetz
Poster
2020 Gastrointestinal Cancers Symposium
The comparison of mFOLFOXIRI with CAOX/SOX as neoadjuvant chemotherapy for locally advanced rectal cancer.
First Author: Tetsuji Terazawa